3 Power Transmission Contractor, Biotech Drug Developer and Automotive Decorative Parts Maker Stocks With a Strong Future Roadmap: Techno Electric & Engineering Company, Anthem Biosciences and SJS Enterprises

Grid contractor, biotech and auto trim stocks offer a focused view of a sector where demand keeps widening. Techno Electric & Engineering Company, Anthem Biosciences and SJS Enterprises cover a power transmission and data centre contractor, a biotech drug development company and an automotive decorative parts maker.

This list covers three grid contractor, biotech and auto trim stocks with complete current figures: Techno Electric & Engineering Company, Anthem Biosciences and SJS Enterprises. Every figure comes from the latest reported financials and the 10 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Grid Contractor, Biotech and Auto Trim Stocks?

Grid contractor, biotech and auto trim stocks are listed companies that build power transmission networks, substations and data centres, help global drug firms develop and make new medicines, and produce decorative badges, lens assemblies and surface parts for vehicles. Their earnings depend on grid and data centre projects, drug outsourcing and vehicle output.

Grid Contractor, Biotech and Auto Trim Stocks at a Glance

On valuation, SJS Enterprises trades at a P/E below the industry P/E, while Techno Electric & Engineering Company and Anthem Biosciences trade above it, which reflects the growth the market already expects. Readers comparing grid contractor, biotech and auto trim stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in grid contractor, biotech and auto trim stocks can use the coming numbers to test whether growth is holding.

Why Do Grid Contractor, Biotech and Auto Trim Stocks Have a Strong Roadmap in India?

Grid contractor, biotech and auto trim stocks have a strong roadmap in India because heavy grid investment, fast growth in data centres and rising outsourcing of drug development and manufacturing keep widening the market for these companies.

• Power contracting. Grids and data centres need new networks.
• Drug development. Global firms outsource discovery and making.
• Auto trim. Buyers prefer premium vehicle finishes.

Why Techno Electric & Engineering Company Features Among These Grid Contractor, Biotech and Auto Trim Stocks

Among the grid contractor, biotech and auto trim stocks on this list, Techno Electric & Engineering Company builds power transmission and distribution infrastructure and also owns and operates wind power assets and data centre capacity.

The company has a return on equity of 11.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 10,943 crore. The stock trades at a P/E of 25.4, above the industry P/E of 22.7.

Revenue rose from Rs 1,154 crore in FY22 to Rs 3,401 crore in FY26, a compound annual growth rate of 31.0%. Net profit grew from Rs 239 crore in FY22 to Rs 449 crore in FY26, which works out to a compound annual growth rate of 17.0%. In the June 2026 quarter, revenue grew 14.8% year on year to Rs 659 crore.

Roadmap: Strong demand for transmission networks and substations supports its engineering order book, while a new data centre platform opens a second growth path. Its operating wind assets add recurring cash flow.

What to watch: Watch the build-out of data centre capacity and the timing of large transmission orders.

Why Anthem Biosciences Features Among These Grid Contractor, Biotech and Auto Trim Stocks

Among the transmission, drug development and vehicle surface shares on this list, Anthem Biosciences is a research-driven contract development and manufacturing organisation that serves global pharma and biotech customers with discovery, development and manufacturing services.

Revenue rose from Rs 1,280 crore in FY22 to Rs 2,280 crore in FY26, a compound annual growth rate of 15.5%. Net profit grew from Rs 406 crore in FY22 to Rs 592 crore in FY26, which works out to a compound annual growth rate of 9.9%.

The company has a return on equity of 19.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 45,546 crore. The stock trades at a P/E of 79.1, above the industry P/E of 36.0.

Roadmap: The company offers an integrated platform from discovery to commercial manufacturing, which makes it a partner for innovator clients. Its biologics, peptides and small-molecule services give it several routes to growth.

What to watch: Monitor the order pipeline from global customers and the ramp-up of newer manufacturing capacity.

Why SJS Enterprises Features Among These Grid Contractor, Biotech and Auto Trim Stocks

Among the three companies on this list, SJS Enterprises makes decorative aesthetic parts such as lenses, badges, decals and appliqués for vehicles, along with products for consumer durables.

In the June 2026 quarter, revenue grew 25.3% year on year to Rs 266 crore, while net profit rose 115.0% to Rs 74.4 crore. Revenue rose from Rs 374 crore in FY22 to Rs 973 crore in FY26, a compound annual growth rate of 27.0%.

Net profit grew from Rs 55.0 crore in FY22 to Rs 172 crore in FY26, which works out to a compound annual growth rate of 32.9%. The company has a return on equity of 19.7%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 6,459 crore. The stock trades at a P/E of 30.5, below the industry P/E of 36.9.

Roadmap: Premium finishes, electric vehicle styling and a rising number of parts per vehicle widen its addressable market. The company has also acquired overseas and domestic businesses, which deepen its product range and customer mix.

What to watch: Follow how newly acquired units are integrated and how premium finishes contribute to the mix.

Techno Electric & Engineering Company vs Anthem Biosciences vs SJS Enterprises on Key Financials

The table below sets the three grid contractor, biotech and auto trim stocks side by side on revenue, profit and margin, using reported figures.

SJS Enterprises posts the highest return on equity in this group at 19.7%. Techno Electric & Engineering Company combines the largest FY26 revenue at Rs 3,401 crore with the fastest revenue growth, a 31.0% compound annual rate. A useful habit with grid contractor, biotech and auto trim stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in Grid Contractor, Biotech and Auto Trim Stocks

Every theme carries risks that deserve a check before any decision. For these grid contractor, biotech and auto trim stocks, the main points are: Long-term transmission, drug development and vehicle surface shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

• Order timing. Project awards can shift between periods.
• Regulatory approvals. Plant inspections and approvals can affect supplies.
• Production cycles. Vehicle output can vary with demand.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter grid contractor, biotech and auto trim stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Grid Contractor, Biotech and Auto Trim Stocks

Grid contractor, biotech and auto trim stocks reward patient research into demand, execution and financial strength. Techno Electric & Engineering Company, Anthem Biosciences and SJS Enterprises each have a clear plan to grow. Based on the 10 November 2026 close, Techno Electric & Engineering Company trades at Rs 946.7, Anthem Biosciences at Rs 958.15 and SJS Enterprises at Rs 2,052.8. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these grid contractor, biotech and auto trim stocks to a watchlist.

Download the Univest iOS App or Univest Android App to track grid contractor, biotech and auto trim stocks, set price alerts and get research-backed stock ideas.

What are grid contractor, biotech and auto trim stocks?

Ans. Grid contractor, biotech and auto trim stocks are listed companies that build power transmission networks, substations and data centres, help global drug firms develop and make new medicines, and produce decorative badges, lens assemblies and surface parts for vehicles. Their earnings depend on grid and data centre projects, drug outsourcing and vehicle output. This list looks at three of them, Techno Electric & Engineering Company, Anthem Biosciences and SJS Enterprises, using reported FY22 to FY26 financials and the 10 November 2026 closing prices.

Which grid contractor, biotech and auto trim stocks are covered in this list?

Ans. This list covers Techno Electric & Engineering Company, Anthem Biosciences and SJS Enterprises. Based on the 10 November 2026 close, Techno Electric & Engineering Company traded at Rs 946.7, Anthem Biosciences at Rs 958.15 and SJS Enterprises at Rs 2,052.8. Their return on equity ranges from 11.4% to 19.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 15.5% to 31.0%.

Why do grid contractor, biotech and auto trim stocks have a strong future roadmap in India?

Ans. Grid contractor, biotech and auto trim stocks have a strong roadmap in India because heavy grid investment, fast growth in data centres and rising outsourcing of drug development and manufacturing keep widening the market for these companies. The main drivers are as follows. Power contracting. Grids and data centres need new networks. Drug development. Global firms outsource discovery and making. Auto trim. Buyers prefer premium vehicle finishes. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Techno Electric & Engineering Company performed financially?

Ans. Revenue rose from Rs 1,154 crore in FY22 to Rs 3,401 crore in FY26, a compound annual growth rate of 31.0%. Net profit grew from Rs 239 crore in FY22 to Rs 449 crore in FY26, which works out to a compound annual growth rate of 17.0%. In the June 2026 quarter, revenue grew 14.8% year on year to Rs 659 crore. The company has a return on equity of 11.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 10,943 crore. The stock trades at a P/E of 25.4, above the industry P/E of 22.7. Looking ahead, strong demand for transmission networks and substations supports its engineering order book, while a new data centre platform opens a second growth path. Its operating wind assets add recurring cash flow.

How has Anthem Biosciences performed financially?

Ans. Revenue rose from Rs 1,280 crore in FY22 to Rs 2,280 crore in FY26, a compound annual growth rate of 15.5%. Net profit grew from Rs 406 crore in FY22 to Rs 592 crore in FY26, which works out to a compound annual growth rate of 9.9%. The company has a return on equity of 19.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 45,546 crore. The stock trades at a P/E of 79.1, above the industry P/E of 36.0. Looking ahead, the company offers an integrated platform from discovery to commercial manufacturing, which makes it a partner for innovator clients. Its biologics, peptides and small-molecule services give it several routes to growth.

How has SJS Enterprises performed financially?

Ans. Revenue rose from Rs 374 crore in FY22 to Rs 973 crore in FY26, a compound annual growth rate of 27.0%. Net profit grew from Rs 55.0 crore in FY22 to Rs 172 crore in FY26, which works out to a compound annual growth rate of 32.9%. In the June 2026 quarter, revenue grew 25.3% year on year to Rs 266 crore, while net profit rose 115.0% to Rs 74.4 crore. The company has a return on equity of 19.7%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 6,459 crore. The stock trades at a P/E of 30.5, below the industry P/E of 36.9. Looking ahead, premium finishes, electric vehicle styling and a rising number of parts per vehicle widen its addressable market. The company has also acquired overseas and domestic businesses, which deepen its product range and customer mix.

What risks should investors check before buying grid contractor, biotech and auto trim stocks?

Ans. Investors should check a few risks before buying grid contractor, biotech and auto trim stocks. Order timing. Project awards can shift between periods. Regulatory approvals. Plant inspections and approvals can affect supplies. Production cycles. Vehicle output can vary with demand. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of grid contractor, biotech and auto trim stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 10 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.